BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Prostate
,
Personalized medicine
,
Acetaminophen
,
rs2300478
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ICAM%201
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for ICAM%201
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-inflammatory HDL effects are impaired in atrial fibrillation.
STAT3 inhibitors attenuate interferon-γ-induced neurotoxicity and inflammatory molecule production b…
Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood o…
mPGES-1-derived prostaglandin E2 stimulates Stat3 to promote podocyte apoptosis.
Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Stan…
Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Viro…
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients
Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ